07/17/2025 7:32 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2025 3:40 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2025 3:47 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144/A | |
06/04/2025 7:31 AM | BioNTech (Subject) Jeggle Helmut Wolfgang (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025 6:20 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 8:00 AM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2025 7:58 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2025 5:14 PM | BioNTech (Subject) Medine GmbH (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025 6:30 AM | BioNTech (Subject) Jeggle Helmut Wolfgang (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025 6:33 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025 5:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for BNTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter.
|
05/05/2025 5:33 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025 6:54 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 5:57 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025 6:00 AM | BioNTech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/27/2025 6:57 AM | BioNTech (Subject) Richardson Ryan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025 6:53 AM | BioNTech (Subject) Medine GmbH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025 6:50 AM | BioNTech (Subject) Poetting Sierk (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025 6:02 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025 5:58 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 6:25 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 6:21 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2024 4:56 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024 4:25 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 5:35 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 4:57 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024 4:50 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024 5:37 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 4:06 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 6:38 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 5:49 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 5:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 5:57 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2024 8:04 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024 4:03 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 7:41 AM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024 3:15 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024 3:13 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024 3:24 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024 3:17 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 4:14 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
A new rule goes live in July — and the banks are quietly cashing in (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
10/02/2024 5:18 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024 7:12 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 3:52 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 4:12 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024 6:14 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024 8:17 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 6:28 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:35 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024 7:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/22/2024 3:31 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024 7:34 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024 5:56 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024 5:32 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024 5:34 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024 8:08 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |